Clinical trial · Observational
Role Of Colposcopy In Evaluation Of Suspicious Cervix
NCT06673680CI-TRIAL-00082257recruitingClinicalTrials.gov clinicaltrialsProvenance
- Source
- ClinicalTrials.gov
- Retrieved
- Sep 8, 2026
- Layer
- normalized (units and labels harmonized; values unchanged)
- Run
- ING-CLINICALTRIALS-20260908-000001
Summary
Brief summary (as posted)
do colposcopy and cervical punch biopsy then compare between findings
Conditions
Conditions (1)
Free-text conditions as registered, with the CancerIndex entity they were reconciled to and the match type.
| Condition (as posted) | Mapped entity | Match | Confidence |
|---|---|---|---|
| Cancer Cervix | — | UNRESOLVED | — |
Interventions
Interventions (1)
| Intervention | Type | Mapped drug | Match |
|---|---|---|---|
| Do colposcopy and cervical punch biopsy then compare between findings | Device | — | UNRESOLVED |
Design
Arms and outcomes
Arms (1)
- label
- colposcopic evaluation
- description
- do colposcopy and cervical punch biopsy then compare between findings
- interventionNames
- Device: Do colposcopy and cervical punch biopsy then compare between findings
Primary outcomes (1)
- measure
- comparison between colposcopic findings of suspicious cervix and histopathologic findings
- timeFrame
- baseline
- description
- Correlate colposcopy and histopathological findings in early screening of suspicious cervix and cervical cancer. And to do a colposcopic evaluation of all cervical lesions and the early detection of all cervical precancer and invasive lesions of the cervix in symptomatic women.
Eligibility
Eligibility (as posted)
- Sex
- Female
- Minimum age
- 18 Years
- Maximum age
- 60 Years
Show eligibility criteria text
Inclusion Criteria: * Age from 30 to 64 years old. * Women with symptoms such as white discharge, post-coital bleeding, and intermenstrual bleeding. * Women with the clinically unhealthy cervix (erosion, bleeding on touch, simple leukoplakia, keratinization) * Women with Pap smear showing dysplasia Exclusion Criteria: * Pregnant women * Women having active vaginal bleeding. * Any past treatment for cervical lesions. * Women having frank growth of cervix. * Women who underwent a hysterectomy.
References
Publications (0)
Data not yet available
No reference posted for this study.